TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction (Q38291327)

1 September 2017

title

TWIST modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction (English)

1 reference

1 September 2017

1 reference

Hiu-Fung Yuen

1

1 reference

1 September 2017

Wai-Kei Kwok

2

1 reference

1 September 2017

Ka-Kui Chan

3

1 reference

1 September 2017

Chee-Wai Chua

4

1 reference

1 September 2017

Yuen-Piu Chan

5

1 reference

1 September 2017

Ying-Ying Chu

6

1 reference

1 September 2017

Yong-Chuan Wong

7

1 reference

1 September 2017

Xianghong Wang

8

1 reference

1 September 2017

Kwok-Wah Chan

9

1 reference

1 September 2017

language of work or name

English

0 references

publication date

2 May 2008

1 reference

1 September 2017

1 reference

1 September 2017

volume

29

1 reference

1 September 2017

issue

8

1 reference

1 September 2017

page(s)

1509-1518

1 reference

1 September 2017

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Active surveillance for prostate cancer: for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Development of prostate cancer treatment: the good news

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

A paradigm for the treatment of prostate cancer bone metastases based on an understanding of tumor cell-microenvironment interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Prostate cancer bone metastases promote both osteolytic and osteoblastic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Role of Wnts in prostate cancer bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Basic mechanisms responsible for osteolytic and osteoblastic bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Therapeutic potential of curcumin in prostate cancer--V: Interference with the osteomimetic properties of hormone refractory C4-2B prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Bone metastasis: Osteoblasts affect growth and adhesion regulons in prostate tumor cells and provoke osteomimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Notch Signaling and ERK Activation Are Important for the Osteomimetic Properties of Prostate Cancer Bone Metastatic Cell Lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Impaired intranuclear trafficking of Runx2 (AML3/CBFA1) transcription factors in breast cancer cells inhibits osteolysis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Expression of helix‐loop‐helix regulatory genes during differentiation of mouse osteoblastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

TWIST, a basic helix-loop-helix transcription factor, can regulate the human osteogenic lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

TWIST inactivation reduces CBFA1/RUNX2 expression and DNA binding to the osteocalcin promoter in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

A twist code determines the onset of osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Msx2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Regulation of osteoblast differentiation by transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Bone morphogenetic protein-6 promotes osteoblastic prostate cancer bone metastases through a dual mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Osteoprotegerin in prostate cancer bone metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

A new human prostate carcinoma cell line, 22Rv1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Whole-genome ChIP-chip analysis of Dorsal, Twist, and Snail suggests integration of diverse patterning processes in the Drosophila embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

FGF-20 and DKK1 are transcriptional targets of beta-catenin and FGF-20 is implicated in cancer and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Biomechanical and molecular regulation of bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

The Wnt-inducible transcription factor Twist1 inhibits chondrogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Expression of Frzb/secreted Frizzled-related protein 3, a secreted Wnt antagonist, in human androgen-independent prostate cancer PC-3 cells suppresses tumor growth and cellular invasiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Drosophila WntD is a target and an inhibitor of the Dorsal/Twist/Snail network in the gastrulating embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGN105

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGN105

1 reference

1 September 2017

1 reference